116 studies found for:
Brain and Spinal Tumors
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Unknown † |
Establishment of a Brain and Spinal Tumor Tissue Bank
|
||||
| 2 | Recruiting |
Natural History of Patients With Brain and Spinal Cord Tumors
|
||||
| 3 | Active, not recruiting |
Study of Brain and Spinal Cord Tumor Growth and Cyst Development in Patients With Von Hippel Lindau Disease
|
||||
| 4 | Recruiting |
A Phase I/II Study of the Photon Radiosurgery System
|
||||
| 5 | Completed |
Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors
|
||||
| 6 | Completed |
Collection of Tumor Tissue, Blood and Spinal Fluid From Patients With Brain or Spine Tumors
|
||||
| 7 | Completed |
Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors
|
||||
| 8 | Completed |
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors
|
||||
| 9 | Recruiting |
Carboplatin and Bevacizumab for Recurrent Ependymoma
|
||||
| 10 | Recruiting |
Application of High Resolution Diffusion-weighted MR Imaging Pulse Sequence in Brain, Head and Neck, and Spine Cancer
|
||||
| 11 | Active, not recruiting |
Dose-Dense Temozolomide + Lapatinib for Recurrent Ependymoma
|
||||
| 12 | Recruiting |
Natural History Study of Patients With Neurofibromatosis Type 2
|
||||
| 13 | Active, not recruiting |
ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors
|
||||
| 14 | Active, not recruiting |
AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors
|
||||
| 15 | Completed |
Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma
|
||||
| 16 | Completed |
FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia
|
||||
| 17 | Recruiting |
Prospective Trial for the Diagnosis and Treatment of Intracranial Germ Cell Tumors
|
||||
| 18 | Recruiting |
MyChoice: An Application of the TFEQ-R18v2
|
||||
| 19 | Terminated |
Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia
|
||||
| 20 | Recruiting |
Comparison of the Effects of Vecuronium and Cisatracurium on Electrophysiologic Monitoring During Neurosurgery
|
† Indicates status has not been verified in more than two years
